{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:37:23Z","timestamp":1792831043795,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","award":["125Z081"],"award-info":[{"award-number":["125Z081"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bioorg.2026.110567","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:35:40Z","timestamp":1790177740000},"page":"110567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and cytotoxic activity evaluation of 1,2,4-Triazole-based Ethanone and Ferrocenylchalcone derivatives: A comparative study"],"prefix":"10.1016","volume":"183","author":[{"given":"Nuran","family":"Kahriman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0131la Can","family":"Osmano\u011fullar\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olcay","family":"Bekircan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110567_bb0005","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bioorg.2017.10.016","article-title":"Azole-hydrazone derivatives: design, synthesis, in vitro biological evaluation, dual EGFR\/HER2 inhibitory activity, cell cycle analysis and molecular docking study as anticancer agents","volume":"76","author":"Labib","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110567_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104271","article-title":"Synthesis and biological evaluation of 3-amino-1,2,4-triazole derivatives as potential anticancer compounds","volume":"104","author":"Grytsai","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110567_bb0015","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2991\/jegh.k.191008.001","article-title":"Current Cancer epidemiology","volume":"9","author":"Mattiuzzi","year":"2019","journal-title":"J. Epidemiol. Glob. Health"},{"key":"10.1016\/j.bioorg.2026.110567_bb0020","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.110567_bb0025","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2026.110567_bb0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cancergen.2024.06.002","article-title":"Cancer treatments: past, present, and future","volume":"286\u2013287","author":"Sonkin","year":"2024","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110567_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-38859-x","article-title":"Empowering drug off-target discovery with metabolic and structural analysis","volume":"14","author":"Chowdhury","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110567_bb0040","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.1016\/j.arabjc.2016.09.015","article-title":"Synthesis and anticancer activity of novel 3,6-disubstituted 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole derivatives","volume":"12","author":"Charitos","year":"2019","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2026.110567_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112652","article-title":"An insight on medicinal attributes of 1,2,4-triazoles","volume":"205","author":"Aggarwal","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110567_bb0050","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1007\/s00044-012-9992-2","article-title":"Design and synthesis of some azole derivatives as potential antimicrobial agents","volume":"21","author":"Sahin","year":"2012","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2026.110567_bb0055","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.ejmech.2019.04.043","article-title":"Antibacterial activity study of 1,2,4-triazole derivatives","volume":"173","author":"Gao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110567_bb0060","first-page":"1","article-title":"A review on emerging impact of Antitubercular activity of 1,2,4-Triazole derivatives","volume":"22","author":"Rangaswamy","year":"2024","journal-title":"Antiinfect. Agents"},{"key":"10.1016\/j.bioorg.2026.110567_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103752","volume":"98","author":"Fadaly","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110567_bb0070","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/1871524915666150209100533","article-title":"1,2,4-Triazole derivatives as potential scaffold for anticonvulsant activity","volume":"15","author":"Kamboj","year":"2015","journal-title":"Cent. Nerv. Syst. Agents Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110567_bb0075","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.ejmech.2017.08.057","article-title":"Asymmetric synthesis of novel triazole derivatives and their in vitro antiviral activity and mechanism of action","volume":"139","author":"Cao","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110567_bb0080","first-page":"733","article-title":"Synthesis of new fluorine-containing 1,2,4-triazole-5-on derivatives with their anti-urease, anti-xanthine oxidase and antioxidant activities activities","author":"Bekircan","year":"2016","journal-title":"Rev. Roum. Chim."},{"key":"10.1016\/j.bioorg.2026.110567_bb0085","doi-asserted-by":"crossref","first-page":"8813","DOI":"10.1002\/slct.201801578","article-title":"A study on synthesis, biological activities and molecular modelling of some novel Trisubstituted 1,2,4-Triazole derivatives","volume":"3","author":"Gultekin","year":"2018","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2026.110567_bb0090","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/ardp.201300344","article-title":"Synthesis of some new 1,2,4-triazole derivatives starting from 3-(4-Chlorophenyl)-5-(4-methoxybenzyl)-4H-1,2,4-triazol with anti-lipase and anti-urease activities","volume":"347","author":"Bekircan","year":"2014","journal-title":"Arch. Pharm. (Weinheim)."},{"key":"10.1016\/j.bioorg.2026.110567_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105493","article-title":"Monoamine oxidase a and B inhibitory activities of 3,5-diphenyl-1,2,4-triazole substituted [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives","volume":"118","author":"Bekircan","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110567_bb0100","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.70059","article-title":"Recent advances in 1,2,4-Triazole-based anticancer agents: structural optimization, mechanisms, and therapeutic potential (2022\u20132025)","volume":"358","author":"Naeem","year":"2025","journal-title":"Arch. Pharm. (Weinheim)."},{"key":"10.1016\/j.bioorg.2026.110567_bb0105","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1200\/JCO.2002.20.3.751","article-title":"Influence of Letrozole and Anastrozole on Total body aromatization and plasma estrogen levels in postmenopausal breast Cancer patients evaluated in a randomized, cross-over study","volume":"20","author":"Geisler","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bioorg.2026.110567_bb0110","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1521-690X(03)00070-8","article-title":"Aromatase inhibitors for chemoprevention","volume":"18","author":"Goss","year":"2004","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.bioorg.2026.110567_bb0115","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/COC.0000000000001159","article-title":"Talazoparib for the treatment of metastatic castration-resistant prostate Cancer a narrative review","volume":"48","author":"Qureshi","year":"2025","journal-title":"American Journal of Clinical Oncology: Cancer Clinical Trials"},{"key":"10.1016\/j.bioorg.2026.110567_bb0120","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/cbdd.12982","article-title":"Piperazine-linked 4-aminoquinoline-chalcone\/ferrocenyl-chalcone conjugates: synthesis and antiplasmodial evaluation","volume":"90","author":"Singh","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2026.110567_bb0125","doi-asserted-by":"crossref","first-page":"91420","DOI":"10.1039\/C6RA18977F","article-title":"Ferrocenyl based pyrazoline derivatives with vanillic core: synthesis and investigation of their biological properties","volume":"6","author":"Burmud\u017eija","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110567_bb0130","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.bmc.2011.01.048","article-title":"Ferrocenyl chalcones versus organic chalcones: a comparative study of their nematocidal activity","volume":"19","author":"Attar","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110567_bb0135","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/cmdc.200600052","article-title":"Synthesis, structure, and in vitro antitumor activity of some glycoside derivatives of ferrocenyl-chalcones and ferrocenyl-pyrazolines","volume":"1","author":"Zsoldos-M\u00e1dy","year":"2006","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.110567_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133708","article-title":"Synthesis, spectral characterization of novel chalcones based oxazines derivatives and screening of their antimicrobial and antioxidant activity","volume":"1268","author":"Suyambulingam","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.110567_bb0145","doi-asserted-by":"crossref","first-page":"5808","DOI":"10.1021\/acsomega.8b00553","article-title":"Synthesis and preliminary antimicrobial analysis of isatin\u2013ferrocene and isatin\u2013ferrocenyl chalcone conjugates","volume":"3","author":"Singh","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.110567_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043456","article-title":"Novel erlotinib\u2013chalcone hybrids diminish resistance in head and neck cancer by inducing multiple cell death mechanisms","volume":"24","author":"Mur\u00e1nyi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110567_bb0155","doi-asserted-by":"crossref","first-page":"496","DOI":"10.5012\/jkcs.2014.58.5.496","article-title":"Ferrocenyl Chalcones with 1- and 2-Naphthalenyl group: spectroscopic characterizations and electrochemical properties","volume":"58","author":"Jeon","year":"2014","journal-title":"J. Korean Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.110567_bb0160","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ica.2011.08.024","article-title":"Ferrocene- and ruthenocene-containing chalcones: a spectroscopic and electrochemical study","volume":"378","author":"Erasmus","year":"2011","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.bioorg.2026.110567_bb0165","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/cmdc.200600052","article-title":"Synthesis, structure, and in vitro antitumor activity of some glycoside derivatives of ferrocenyl-chalcones and ferrocenyl-pyrazolines","volume":"1","author":"Zsoldos-M\u00e1dy","year":"2006","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.110567_bb0170","doi-asserted-by":"crossref","first-page":"34377","DOI":"10.1021\/acsomega.3c01830","article-title":"Synthesis of novel heterocyclic Ferrocenyl Chalcones and their biological evaluation","volume":"8","author":"Alsina-S\u00e1nchez","year":"2023","journal-title":"ACS Omega"},{"issue":"9","key":"10.1016\/j.bioorg.2026.110567_bb0175","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s11626-015-9919-6","article-title":"Some ferrocenyl chalcones as useful candidates for cancer treatment","volume":"51","author":"Janka","year":"2015","journal-title":"In Vitro Cell. Dev. Biol. Anim."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110567_bb0180","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s00044-016-1509-y","article-title":"Synthesis and in vitro biological activities of ferrocenyl\u2013chalcone amides","volume":"25","author":"Smit","year":"2016","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2026.110567_bb0185","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1016\/j.jorganchem.2006.02.035","article-title":"Synthesis and biological activities of new 1H-1,2,4-triazole derivatives containing ferrocenyl moiety","volume":"691","author":"Liu","year":"2006","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2026.110567_bb0190","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jorganchem.2004.11.028","article-title":"Synthesis, structures and biological activity research of novel ferrocenyl-containing 1H-1,2,4-triazole derivatives","volume":"690","author":"Jin","year":"2005","journal-title":"J. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2026.110567_bb0195","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/aoc.410","article-title":"Preparation, characterization and biological activities of novel ferrocenyl-substituted azaheterocycle compounds","volume":"17","author":"Fang","year":"2003","journal-title":"Appl. Organomet. Chem."},{"key":"10.1016\/j.bioorg.2026.110567_bb0200","doi-asserted-by":"crossref","first-page":"112109","DOI":"10.1016\/j.ejmech.2020.112109","article-title":"Ferrocene-containing hybrids as potential anticancer agents: current developments, mechanisms of action and structure-activity relationships","volume":"190","author":"Wang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110567_bb0205","series-title":"ACD\/Labs Software, Educatures Pack","author":"Advanced Chemistry Development Inc","year":"2001"},{"key":"10.1016\/j.bioorg.2026.110567_bb0210","series-title":"Novel compounds","author":"Matthias","year":"2013"},{"key":"10.1016\/j.bioorg.2026.110567_bb0215","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1248\/cpb.23.955","article-title":"1, 2, 4-Triazoles. IV. Tautomerism of 3, 5-disubstituted 1, 2, 4-triazoles","volume":"23","author":"Kubota","year":"1975","journal-title":"Chem. Pharm. Bull. (Tokyo)."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110567_bb0220","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11224-022-02057-0","article-title":"Tautomeric behavior of 1,2,4-triazole derivatives: combined spectroscopic and theoretical study","volume":"34","author":"Pylypenko","year":"2022","journal-title":"Struct. Chem."},{"key":"10.1016\/j.bioorg.2026.110567_bb0225","doi-asserted-by":"crossref","first-page":"78422","DOI":"10.1039\/C5RA15919A","article-title":"Mild Cu(OAc)2\u00b7H2O-catalyzed synthesis of multi-substituted 1,2,4-triazoles from amidines with nitriles via a N\u2013N\/C\u2013N coupling","volume":"5","author":"Wang","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110567_bb0230","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/14786419.2013.843178","article-title":"Antifungal dimeric chalcone derivative kamalachalcone E from Mallotus philippinensis","volume":"28","author":"Kulkarni","year":"2014","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.bioorg.2026.110567_bb0235","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/jac\/dku427","article-title":"Antifungal activity of 6-quinolinyl N-oxide chalcones against Paracoccidioides","volume":"70","author":"De S\u00e1","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bioorg.2026.110567_bb0240","doi-asserted-by":"crossref","first-page":"19194","DOI":"10.1021\/acsomega.3c01035","article-title":"Synthesis and pharmacological activities of Chalcone and its derivatives bearing N-heterocyclic scaffolds: a review","volume":"8","author":"Mezgebe","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.110567_bb0245","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/ardp.201400215","article-title":"Synthesis and anti-cancer activity evaluation of new dimethoxylated chalcone and flavanone analogs","volume":"347","author":"Ketabforoosh","year":"2014","journal-title":"Arch. Pharm. (Weinheim)."},{"key":"10.1016\/j.bioorg.2026.110567_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112109","article-title":"Ferrocene-containing hybrids as potential anticancer agents: current developments, mechanisms of action and structure-activity relationships","volume":"190","author":"Wang","year":"2020","journal-title":"Eur. J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682601103X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682601103X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T08:03:40Z","timestamp":1792829020000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682601103X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":50,"alternative-id":["S004520682601103X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110567","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and cytotoxic activity evaluation of 1,2,4-Triazole-based Ethanone and Ferrocenylchalcone derivatives: A comparative study","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110567","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110567"}}